Tectonic Therapeutic Inc reports results for the quarter ended March 31 - Earnings Summary

Tectonic Therapeutic

08/05/2025 21:46

Tectonic Therapeutic Inc TECX.OQ reported a quarterly adjusted loss of 93 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.80.  The mean expectation of four analysts for the quarter was for a loss of $1.09 per share. Wall Street expected results to range from $-1.19 to $-1.05 per share.

Reported revenue was zero​; analysts expected zero.

Tectonic Therapeutic Inc's reported EPS for the quarter was a loss of 93 cents​.

The company reported a quarterly loss of $15.91 million.

Tectonic Therapeutic Inc shares had risen by 7.1% this quarter and lost 58.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 13.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Tectonic Therapeutic Inc is $72.50

This summary was machine generated from LSEG data May 8 at 08:46 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-1.09
-0.93
Beat
Dec. 31 2024
-1.39
-0.84
Beat
Sep. 30 2024
-0.82
-1.20
Missed
Jun. 30 2024
-1.50
-4.34
Missed